Advertisement

Topics

Arkema Boosts Specialties with ArrMaz Buy

02:54 EDT 17 May 2019 | CHEManager

Arkema has agreed to buy ArrMaz, a US-based producer of specialty surfactants for crop nutrition, mining and infrastructure, from private equity group Golden Capital for $570 million. The French chemical company said the “milestone” acquisition is another step toward its target of achieving more than 80% of sales in specialties by 2023.

Original Article: Arkema Boosts Specialties with ArrMaz Buy

NEXT ARTICLE

More From BioPortfolio on "Arkema Boosts Specialties with ArrMaz Buy"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...